People of Medicine by Design: Katie Lye
"I hope that my work will one day be used across a wide range of applications. With all the complexities and unknowns of degenerative diseases, it’s important for us to explore new ideas."
Recipients of third round of Medicine by Design’s Pivotal Experiment Fund announced
Fund advances research discoveries to real benefit for human health
Medicine by Design launches funding for Convergent Working Groups to take strategic action in regenerative medicine
Convergent Working Groups aim to bring wide-ranging expertise and perspectives together
Medicine by Design announces new strategic plan to advance regenerative medicine and transform healthcare globally
Community collaboration drove the new commitments in bold five-year plan
Immunology expert is Medicine by Design’s newest investigator
Matthew Buechler recently joined the Department of Immunology as an assistant professor.
People of Medicine by Design: Amy Wong
"This is a very exciting time for regenerative medicine. We can make all sorts of cell types from stem cells and potentially use these cells for cell replacement therapy or use them to understand diseases or find new therapies."
Medicine by Design expands Entrepreneur-in-Residence program to drive research translation and commercialization
Two new advisors with decades of industry experience join the program as advisors.
A Leap into the Future: Assistant Professor Michael Garton on the promise of synthetic biology
The Leap into the Future series looks at emerging areas or aspects of regenerative medicine.
Clinical translation event kicks-off strategic partnership between Medicine by Design and the Stem Cell Network
Strategic partnership focuses on training the next generation of leaders, scientists and entrepreneurs.
Medicine by Design highlighted at MaRS Impact Health 2022 with new video, researchers in sessions
The conference brought together entrepreneurs, academics, investors and policymakers.
DTPX Therapeutics and Azane Therapeutics are the top teams at the Building a Biotech Venture Pitch Competition
Research grants awarded to products that could impact cancer and rare genetic diseases.
Medicine by Design-funded research uncovers method of stratifying cancer cells
Research reveals a potential way to tailor acute myeloid leukemia (AML) therapies to individual patients.
People of Medicine by Design: Omar F. Khan
“In my lab, we approach regenerative and preventative medicine from a genetic angle. Our goal is to help people's own cells repair damage and prevent disease.”
Six teams to compete for two grants at Medicine by Design’s Building a Biotech Venture Pitch Competition, $25,000 or $10,000
Trainee-led teams will pitch their ideas in front of expert judges for the chance to receive one of two research funding grants.
Several Medicine by Design-funded projects to be further advanced by Stem Cell Network investment
The Medicine by Design-funded researchers awarded come from disciplines that include stem cell biology, neuroscience and biomedical engineering.